3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
6
Prostatic Neoplasms
3
Oropharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Laryngeal Neoplasms
2
Astrocytoma
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
Oligodendroglioma
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Advanced Glioblastoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Interventions
Oxaliplatin
3
Leucovorin
3
Fluorouracil
3
Capecitabine
3
zolbetuximab
2
trastuzumab deruxtecan
2
pembrolizumab
2
Ramucirumab
2
Paclitaxel
2
repotrectinib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
durvalumab
1
darolutamide
1
aldesleukin
1
Vinorelbine
1
Radiosurgery
1
Radiation
1
Prednisone
1
Prednisolone
1
Pemetrexed
1
PF06821497
1
Nivolumab
1
Negative-Pressure Wound Therapy
1
Microscopy, Confocal
1
MORAb-202
1
Irinotecan
1
Immunotherapy
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.